NuVasive's net sales up 4.4% in Q1: 5 notes

Spinal Tech

NuVasive saw an increase in net sales, but a decrease in net income during the first quarter of 2021.

Five takeaways from its financial results released May 5:

1. Net sales were $271.2 million. That's a 4.4 percent increase compared to the same period last year. The increase was credited to month-over-month improvement in U.S. procedural volumes and low double-digit international growth.

2. The company saw a GAAP net loss of $7.5 million, or diluted loss per share of $0.15.

3. NuVasive had a non-GAAP net income of $19 million, which is down 25.2 percent compared to the first quarter last year.

4. NuVasive retired $650 million of convertible debt at maturity and funded the $150 million payment to acquire Simplify Medical.

5. The company has seen positive feedback on the Simplify Medical acquisition, and it plans to launch the Pulse platform later this year.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers